Drugs / LY3045697
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01821703 | May → Sep 2013 | — | Eli Lilly and Company | Completed | No outcome recorded |
| Phase 1 | NCT01750853 | Jan → Jul 2013 | — | Eli Lilly and Company | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LY3045697 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01750853 ↗ |
| Route | Oral | “LY3045697 administered once orally” NCT01750853 ↗ |